Racial differences in inflammation and outcomes of aging among kidney transplant candidates

Abstract Background Inflammation is more common among African Americans (AAs), and it is associated with frailty, poor physical performance, and mortality in community-dwelling older adults. Given the elevated inflammation levels among end-stage renal disease (ESRD) patients, inflammation may be ass...

Full description

Bibliographic Details
Main Authors: Prakriti Shrestha, Christine E. Haugen, Nadia M. Chu, Ashton Shaffer, Jacqueline Garonzik-Wang, Silas P. Norman, Jeremy D. Walston, Dorry L. Segev, Mara A. McAdams-DeMarco
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Nephrology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12882-019-1360-8
_version_ 1819241545407135744
author Prakriti Shrestha
Christine E. Haugen
Nadia M. Chu
Ashton Shaffer
Jacqueline Garonzik-Wang
Silas P. Norman
Jeremy D. Walston
Dorry L. Segev
Mara A. McAdams-DeMarco
author_facet Prakriti Shrestha
Christine E. Haugen
Nadia M. Chu
Ashton Shaffer
Jacqueline Garonzik-Wang
Silas P. Norman
Jeremy D. Walston
Dorry L. Segev
Mara A. McAdams-DeMarco
author_sort Prakriti Shrestha
collection DOAJ
description Abstract Background Inflammation is more common among African Americans (AAs), and it is associated with frailty, poor physical performance, and mortality in community-dwelling older adults. Given the elevated inflammation levels among end-stage renal disease (ESRD) patients, inflammation may be associated with adverse health outcomes such as frailty, physical impairment, and poor health-related quality of life (HRQOL), and these associations may differ between AA and non-AA ESRD patients. Methods One thousand three ESRD participants were recruited at kidney transplant evaluation (4/2014–5/2017), and inflammatory markers (interleukin-6 [IL-6], tumor necrosis factor-a receptor-1 [TNFR1], C-reactive protein [CRP]) were measured. We quantified the association with frailty (Fried phenotype), physical impairment (Short Physical Performance Battery [SPPB]), and fair/poor HRQOL at evaluation using adjusted modified Poisson regression and tested whether these associations differed by race (AA vs. non-AA). Results Non-AAs had lower levels of TNFR1 (9.7 ng/ml vs 14.0 ng/ml, p < 0.001) and inflammatory index (6.7 vs 6.8, p < 0.001) compared to AAs, but similar levels of IL-6 (4.5 pg/ml vs 4.3 pg/ml, p > 0.9) and CRP (4.7 μg/ml vs 4.9 μg/ml, p = 0.4). Non-AAs had an increased risk of frailty with elevated IL-6 (RR = 1.58, 95% CI:1.27–1.96, p < 0.001), TNFR1 (RR = 1.60, 95% CI:1.25–2.05, p < 0.001), CRP (RR = 1.41, 95% CI:1.10–1.82, p < 0.01), and inflammatory index (RR = 1.82, 95% CI:1.44–2.31, p < 0.001). The associations between elevated inflammatory markers and frailty were not present among AAs. Similar results were seen with SPPB impairment and poor/fair HRQOL. Conclusions Non-AAs with elevated inflammatory markers may need closer follow-up and may benefit from prehabilitation to improve physical function, reduce frailty burden, and improve quality of life prior to transplant.
first_indexed 2024-12-23T14:25:37Z
format Article
id doaj.art-d336b946b7a44d79a8b4d667bbc1f63a
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-23T14:25:37Z
publishDate 2019-05-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-d336b946b7a44d79a8b4d667bbc1f63a2022-12-21T17:43:41ZengBMCBMC Nephrology1471-23692019-05-012011810.1186/s12882-019-1360-8Racial differences in inflammation and outcomes of aging among kidney transplant candidatesPrakriti Shrestha0Christine E. Haugen1Nadia M. Chu2Ashton Shaffer3Jacqueline Garonzik-Wang4Silas P. Norman5Jeremy D. Walston6Dorry L. Segev7Mara A. McAdams-DeMarco8Department of Surgery, Johns Hopkins University School of MedicineDepartment of Surgery, Johns Hopkins University School of MedicineDepartment of Surgery, Johns Hopkins University School of MedicineDepartment of Surgery, Johns Hopkins University School of MedicineDepartment of Surgery, Johns Hopkins University School of MedicineDepartment of Medicine, Division of Nephrology, University of MichiganDepartment of Medicine, Division of Geriatrics, Johns Hopkins University School of MedicineDepartment of Surgery, Johns Hopkins University School of MedicineDepartment of Surgery, Johns Hopkins University School of MedicineAbstract Background Inflammation is more common among African Americans (AAs), and it is associated with frailty, poor physical performance, and mortality in community-dwelling older adults. Given the elevated inflammation levels among end-stage renal disease (ESRD) patients, inflammation may be associated with adverse health outcomes such as frailty, physical impairment, and poor health-related quality of life (HRQOL), and these associations may differ between AA and non-AA ESRD patients. Methods One thousand three ESRD participants were recruited at kidney transplant evaluation (4/2014–5/2017), and inflammatory markers (interleukin-6 [IL-6], tumor necrosis factor-a receptor-1 [TNFR1], C-reactive protein [CRP]) were measured. We quantified the association with frailty (Fried phenotype), physical impairment (Short Physical Performance Battery [SPPB]), and fair/poor HRQOL at evaluation using adjusted modified Poisson regression and tested whether these associations differed by race (AA vs. non-AA). Results Non-AAs had lower levels of TNFR1 (9.7 ng/ml vs 14.0 ng/ml, p < 0.001) and inflammatory index (6.7 vs 6.8, p < 0.001) compared to AAs, but similar levels of IL-6 (4.5 pg/ml vs 4.3 pg/ml, p > 0.9) and CRP (4.7 μg/ml vs 4.9 μg/ml, p = 0.4). Non-AAs had an increased risk of frailty with elevated IL-6 (RR = 1.58, 95% CI:1.27–1.96, p < 0.001), TNFR1 (RR = 1.60, 95% CI:1.25–2.05, p < 0.001), CRP (RR = 1.41, 95% CI:1.10–1.82, p < 0.01), and inflammatory index (RR = 1.82, 95% CI:1.44–2.31, p < 0.001). The associations between elevated inflammatory markers and frailty were not present among AAs. Similar results were seen with SPPB impairment and poor/fair HRQOL. Conclusions Non-AAs with elevated inflammatory markers may need closer follow-up and may benefit from prehabilitation to improve physical function, reduce frailty burden, and improve quality of life prior to transplant.http://link.springer.com/article/10.1186/s12882-019-1360-8End-stage renal diseaseInflammationRaceFrailtyHRQOL
spellingShingle Prakriti Shrestha
Christine E. Haugen
Nadia M. Chu
Ashton Shaffer
Jacqueline Garonzik-Wang
Silas P. Norman
Jeremy D. Walston
Dorry L. Segev
Mara A. McAdams-DeMarco
Racial differences in inflammation and outcomes of aging among kidney transplant candidates
BMC Nephrology
End-stage renal disease
Inflammation
Race
Frailty
HRQOL
title Racial differences in inflammation and outcomes of aging among kidney transplant candidates
title_full Racial differences in inflammation and outcomes of aging among kidney transplant candidates
title_fullStr Racial differences in inflammation and outcomes of aging among kidney transplant candidates
title_full_unstemmed Racial differences in inflammation and outcomes of aging among kidney transplant candidates
title_short Racial differences in inflammation and outcomes of aging among kidney transplant candidates
title_sort racial differences in inflammation and outcomes of aging among kidney transplant candidates
topic End-stage renal disease
Inflammation
Race
Frailty
HRQOL
url http://link.springer.com/article/10.1186/s12882-019-1360-8
work_keys_str_mv AT prakritishrestha racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT christineehaugen racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT nadiamchu racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT ashtonshaffer racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT jacquelinegaronzikwang racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT silaspnorman racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT jeremydwalston racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT dorrylsegev racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates
AT maraamcadamsdemarco racialdifferencesininflammationandoutcomesofagingamongkidneytransplantcandidates